Capital Research Global Investors Penumbra Inc Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Penumbra Inc stock. As of the latest transaction made, Capital Research Global Investors holds 1,130,866 shares of PEN stock, worth $204 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,130,866
Previous 2,677,789
57.77%
Holding current value
$204 Million
Previous $674 Million
62.53%
% of portfolio
0.06%
Previous 0.17%
Shares
15 transactions
Others Institutions Holding PEN
# of Institutions
387Shares Held
27.5MCall Options Held
412KPut Options Held
292K-
Black Rock Inc. New York, NY4.06MShares$731 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$664 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$545 Million0.08% of portfolio
-
State Street Corp Boston, MA1.2MShares$217 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.08MShares$195 Million1.43% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $6.82B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...